Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.43 AUD | -3.37% | +11.69% | +24.64% |
03:03am | Canaccord Starts Immutep at Buy, Price Target is AU$1.00 | MT |
Apr. 24 | Immutep Shows Positive Data in Trial to Treat Squamous Cell Cancers in Head, Neck | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.64% | 347M | |
+1.77% | 42.86B | |
+45.49% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |
- Stock Market
- Equities
- IMM Stock
- News Immutep Limited
- Immutep's Efti, Merc'k's KEYTRUDA Combination Raises Survival for NSCLC Patients; Shares Jump 20%